Medline Inc.
MDLN · XNASCIK 2046386fmd_0X5NE9AQ41MS865E8TE2H55CSJManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2023 to Sep 26, 2026, 9 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | 23,231 | 25,507 | 28,432 |
| Cost of revenue | 17,346 | 18,531 | 20,914 |
| Gross profit | 5,885 | 6,976 | 7,518 |
| Research and development | 60 | 67 | 80 |
| Selling, general and administrative | 3,867 | 4,108 | 4,524 |
| Total operating expenses | 4,635 | 4,830 | 5,306 |
| Operating income | 1,250 | 2,146 | 2,212 |
| Interest expense | 1,213 | 1,144 | 945 |
| Interest and investment income | 237 | 280 | 133 |
| Other non-operating income (expense) | (986) | (900) | (964) |
| Income before taxes | 264 | 1,246 | 1,248 |
| Income tax expense | 30 | 46 | 91 |
| Net income from continuing operations | 234 | 1,200 | 1,157 |
| Net income | 234 | 1,163 | 1,159 |